GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Cash Flow for Lease Financing

Entheon Biomedical (XCNQ:ENBI) Cash Flow for Lease Financing : C$0.00 Mil (TTM As of Nov. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Cash Flow for Lease Financing?

Entheon Biomedical's Cash Flow for Lease Financing for the three months ended in Nov. 2023 was C$0.00 Mil. Entheon Biomedical's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Nov. 2023 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Aug. 2023 ), Entheon Biomedical's Cash Flow for Lease Financing remained the same in Nov. 2023 (C$0.00 Mil).

Entheon Biomedical Cash Flow for Lease Financing Historical Data

The historical data trend for Entheon Biomedical's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Cash Flow for Lease Financing Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Entheon Biomedical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Entheon Biomedical Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XCNQ:MYND XCNQ:ABRT XCNQ:WESA.X TSXV:BTI XCNQ:HAVN TSXV:IBO XCNQ:GTTX TSXV:APC.H XCNQ:MOOD XCNQ:NSHS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ENTBF:USA 1XU1:Germany
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Website
https://www.entheonbiomedical.com
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines